1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,159 | 0,199 | 03.02. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.01. | Notice of Extraordinary General Meeting 2026 in Qlife Holding AB | 2 | Cision News | ||
| 26.01. | QLife Holding AB: Qlife submits Egoo PHE home testing system for regulatory approval | 320 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, today announces that the Company has formally submitted its Egoo PHE home-testing system for regulatory approval... ► Artikel lesen | |
| 22.01. | QLife Holding AB: Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and postpones the exercise period of warrants TO7 | 73 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| QLIFE Aktie jetzt für 0€ handeln | |||||
| 19.01. | QLIFE HOLDING AB: Qlife prepares for pharmacy testing in Nordic markets | 1 | Cision News | ||
| 15.01. | QLife Holding AB: Egoo Health achieves breakthrough precision in key diabetes biomarker test, paving the way for partnerships | 108 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, together with its partner Hipro Biotechnology Co., Ltd. ("Hipro"), announces a major milestone: the Egoo HbA1c... ► Artikel lesen | |
| 23.12.25 | QLife Holding AB: Qlife provides end-year operational update on key issues | 489 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, provides a year-end operational update on key issues.
Diabetes data
Egoo Health has achieved breakthrough... ► Artikel lesen | |
| 16.12.25 | QLife Holding AB: The Letter of Intent with Hipro Biotechnology regarding the reverse takeover has been extended until 31 December 2026 and the valuation term will re-evaluated once a structure has been established | 231 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") announces an extension of the non-binding Letter of Intent regarding the potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd.... ► Artikel lesen | |
| 16.12.25 | QLife Holding AB: Qlife and Hipro sign exclusive commercial agreement covering Qlife's sale of Hipro products in EU and US markets | 155 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a first mover in clinical-grade home diagnostics, today announced that it has entered into an exclusive commercial agreement with Hipro Biotechnology Co.... ► Artikel lesen | |
| 12.12.25 | QLife Holding AB: Egoo Health powers AI-driven personalized diabetes management in China | 204 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") is proud to announce that its Egoo Health blood testing platform will play a central role in a groundbreaking project launched by Hipro Biotechnology Co.... ► Artikel lesen | |
| 05.12.25 | QLife Holding AB: Qlife's Birmingham PKU clinical trial published with strong results - key milestone toward CE-mark submission and market launch | 137 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") a first mover in clinical-grade home diagnostics, announces publication of the clinical study for PKU children and adolescents under 18 years of age. The... ► Artikel lesen | |
| 14.11.25 | QLife Holding AB: Update on the reverse takeover process - "Red Chip" structure will not be approved by Nasdaq - other structures are pursued | 248 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or "the Company") and Hipro Biotechnology Co., Ltd. ("Hipro") are working on the planned reverse takeover, as announced in press releases on 5 June 2025 and 5 October 2025.... ► Artikel lesen | |
| 12.11.25 | Qlife Holding AB Q3 Sales Decline | 1 | RTTNews | ||
| 12.11.25 | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q3, July - September 2025 | 139 | GlobeNewswire (Europe) | Advancing Integration & Innovation: Building a Diagnostics Powerhouse
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary... ► Artikel lesen | |
| 05.10.25 | QLife Holding AB: The Letter of Intent with Hipro Biotechnology Co., Ltd. regarding reverse takeover has been extended | 110 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") announces an extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd. ("Hipro"). The... ► Artikel lesen | |
| 22.09.25 | Qlife Holding AB announces the outcome of the exercise of warrants series TO 6 | 1 | Cision News | ||
| 15.09.25 | QLife Holding AB: Qlife announces additional product line and progresses two new tests into clinical trials | 165 | GlobeNewswire (Europe) | Qlife, a first mover in clinical-grade home diagnostics, and its partner Hipro Biotechnology are advancing two additional biomarker tests-nt-proBNP and potassium-into clinical trials targeting Congestive... ► Artikel lesen | |
| 27.08.25 | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q2, April to June 2025 | 254 | GlobeNewswire (Europe) | Towards a merger with a vision
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - second quarter 2025
Revenue... ► Artikel lesen | |
| 27.08.25 | QLife Holding AB: Progress update on the reverse takeover process between Qlife and Hipro | 193 | GlobeNewswire (Europe) | Gothenburg, Sweden - Qlife Holding AB ("Qlife" or the "Company") and Hipro Biotechnology Co., Ltd. ("Hipro") remain fully committed to completing the transaction announced in the Letter of Intent signed... ► Artikel lesen | |
| 21.08.25 | Qlife Holding AB increases existing credit facility and extends the maturity date | 1 | Cision News | ||
| 21.08.25 | QLIFE HOLDING AB: Qlife together with Birmingham Women's and Children's NHS Foundation Trust achieve positive results for its rare disease self-test PHE product | 2 | Cision News |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,150 | -0,45 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Der Aktienkurs der Münchner spiegle die mittelfristigen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,890 | +2,07 % | Fresenius Medical Care AG: Das Übergangsjahr 2026 rückt zunehmend in den Fokus. KAUFEN. | Die jüngste Konsensaktualisierung von Fresenius Medical Care lenkt den Fokus auf das Geschäftsjahr 2026 als ein Übergangsjahr. Die Markterwartungen deuten auf eine schrittweise operative Erholung hin... ► Artikel lesen | |
| FRESENIUS | 48,990 | +2,15 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
28.01.2026 /... ► Artikel lesen | |
| PROGYNY | 23,240 | -4,01 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,030 | -3,61 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,560 | -1,01 % | Silber bald bei 200 USD? Teuer einkaufen oder Chance nutzen bei CSG, American Atomics und Carl Zeiss Meditec | Nach einem nervösen Jahresstart rücken Rohstoffe und Energiefragen wieder klar in den Fokus der Kapitalmärkte. Die jüngsten Diskussionen um Handelszölle und geopolitische Abhängigkeiten, die auch das... ► Artikel lesen | |
| HEARTFLOW | 28,370 | 0,00 % | Heartflow: Wells Fargo startet Coverage mit "Overweight" und Kursziel von 38 $ | ||
| GENEDX | 95,16 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 22,890 | 0,00 % | Alignment Healthcare (ALHC) Drops 12% on Medicare Flat Funding | ||
| PROCEPT BIOROBOTICS | 29,200 | +0,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 25,120 | -1,18 % | Carl Zeiss Meditec, Fuchs, Gerresheimer, Hensoldt, Lanxess, Renk: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| UNITEDHEALTH | 239,50 | -0,35 % | UnitedHealth: Historisches Kursbeben - die Hintergründe | Lange Gesichter bei den Aktionären von UnitedHealth. Am gestrigen Dienstag brach der Dow-Jones-Titel um knapp ein Fünftel ein, womit eine nachhaltige Trendwende bei den Anteilen des größten US-Krankenversicherers... ► Artikel lesen | |
| LUMEXA IMAGING | 11,800 | -3,75 % | Lumexa Imaging's Dr. Kemp elected to RSNA board | ||
| BETA BIONICS | 14,460 | +5,55 % | Beta Bionics: TD Cowen bleibt trotz FDA-Warnung bei "Hold"-Einstufung | ||
| AVEANNA HEALTHCARE | 8,470 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen |
QLIFE HOLDING AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +21,54 % bei einem Aktienkurs von 0,198 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QLIFE HOLDING AB finden Sie auf Wallstreet Online.